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Abstract 
Background: When an ecological system is exposed to an anthropogenic toxin, each species has an 
idiosyncratic sensitivity, but it is reasonable to expect some generality in response, especially among 
related species such as bees. If two species are similarly sensitive to a toxin their dose-response 
relationships will be similar. We propose a method to facilitate comparison between dose-response 
relationships, namely the response-response relationship, which can be applied to any biomarkers 
whose responses to the same pollutant are measured across a similar range of doses.  We apply the 
method to bumble bees (Bombus terrestris) and honey bees (Apis mellifera) exposed to a dietary 
pesticide, imidacloprid, and we investigate both lethal and sublethal biomarkers.  
Results: We found cross-species similarity in dose-dependent responses, but only in certain sublethal 
biomarkers. In honey bees, sublethal biomarkers were more sensitive than mortality.  In bumble bees, 
fecundity was the most sensitive biomarker.  
Conclusion: Our results provisionally suggest the existence of cross-species generalities. The greater 
sensitivity of sublethal biomarkers than mortality suggests that testing protocols which are overly 
focussed on mortality may underestimate the ecological impacts of toxic pollutants. 
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1. Introduction 
Ecological systems are often richly complex, but scientists are constrained logistically to study only a 
few of their facets. When an ecological system is exposed to an anthropogenic toxin, each species has 
an idiosyncratic sensitivity to the pollutant. However, it is reasonable to expect that some generalities 
about the impacts of pollutants can be made and transferred from those organisms that have been 
studied to those that have not1.  In the case of bees, for example, it will be valuable to know whether 
the impacts of pollutants on non-Apis bees can be inferred from the results of studies on honey bees 
(Apis mellifera L.), which are the focal species of current toxicological regulatory testing2. Based on 
overall toxicity, a previous comparative study3 indicated broad similarity in the sensitivity of honey 
bees, bumble bees and solitary bees to a wide range of pesticide pollutants. Here, we investigate the 
detailed dose-dependence of various biomarkers, including sublethal endpoints.  
The sensitivity of a species to a toxicological stressor is evident in the dose-response relationship, or 
exposure-response relationship4. Conventionally, the dose-response relationship is a simple graph 
that relates the magnitude of the stressor (e.g. the dietary concentration or the ingested amount of 
the pollutant) to the organism’s response, which is quantified by a change in a specified biomarker, or 
endpoint (e.g. a physiological or behavioural variable, reproductive success, or mortality). If two 
species are similarly sensitive to a toxin, their dose-response relationships will be similar. 
Consequently, the recognition of toxicological generalities relies in part on our ability to recognize 
similarities among dose-response relationships. Here, we propose a method to aid comparison.  
It is possible to compare two dose-response relationships simply by overlaying the plots on the same 
pair of axes. This is feasible when we compare two biomarkers whose responses are measured across 
a similar range of doses of the same pollutant. However, a new plot based on the same data facilitates 
the rapid evaluation of the differences between the two relationships.  The plot is a response-
response relationship (see Methods) and its shape is diagnostic for the relative sensitivity of the two 
responding biomarkers. 
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We need not be limited to comparing the sensitivity of different species. It is also valuable to compare 
the sensitivity of different biomarkers in the same species. For example, mortality is typically the focal 
biomarker for toxicological studies in bees and its cardinal value is the LD50, the dosage required to 
kill half of the exposed individuals. The LD50 is conventionally used to compare potency among 
pollutants. However, if we are interested in ecologically important impacts, then we should also 
inquire about a toxin’s effects on reproduction, because population dynamics are influenced by birth 
rates as well as death rates5. It is therefore valuable to know whether fecundity is a more or less 
sensitive biomarker than mortality, because this determines whether the overall demographic 
toxicity of the pollutant is correctly indicated by its LD50. We can establish the relative sensitivity of 
these demographically important variables from a suitably arranged response-response relationship. 
2. Experimental methods 
Consider two conventional dose-response relationships, A and B, that are curves over the same range 
of dosages of the same toxin.  Each point on relationship A is denoted (DA,RA) and (DB,RB) denotes 
points on relationship B. Each point on the response-response relationship is given by (RA,RB) when DA 
= DB. 
If the two dose-response relationships, A and B, exhibit identical levels of sensitivity, then RA = RB for 
any DA = DB and the response-response relationship will be the line of equivalence, i.e. y = x. If instead 
one biomarker is more sensitive, the response-response relationship will deviate away from the line of 
equivalence and towards the axis that denotes the response of the more sensitive biomarker. 
2.1 Case study 1: performance in honey bees vs. feeding in bumble bees exposed to 
imidacloprid 
We compare the sensitivity of honey bees and bumble bees to dietary residues of the neonicotinoid 
pesticide, imidacloprid. Imidacloprid is a widely-used neonicotinoid pesticide whose residues appear 
in the nectar and pollen of treated crops6. It disrupts the insect nervous system by acting on nicotinic 
acetylcholine receptors7 and it causes both mortality and various sublethal effects8. 
The dose-response relationship for honey bees was obtained from a meta-analysis of experiments 
testing the effects of dietary imidacloprid on honey bees9, which established a dose-response 
relationship whose biomarker was average performance across a variety of sublethal biomarkers, 
which included learning ability of individuals10, flight activity at the hive11, and brood production12,13. 
Honey bee performance was defined relative to the biomarker’s magnitude in undosed bees and the 
consensus dose-response relationship was described by: relative performance(%) = 100*[1 – 
0.06exp(0.478ln(dose))], where dose has units of μg imidacloprid L-1 feeder syrup9.   
The dose-response relationship in bumble bees was established in laboratory experiments on 
individually caged bumble bees (Cresswell, unpublished) that were fed ad libitum on syrup (50% 
inverted sucrose; Attracker, Koppert B.V., Berkel en Rodenrijs, NL) containing imidacloprid at a range 
of ten dosages. The bees (Bombus terrestris L.) were obtained as domesticated colonies from a 
commercial supplier (Natupol Beehive, Koppert B.V., Berkel en Rodenrijs, NL). Bees were maintained in 
a controlled environment room (temperature 25°C, 40% relative humidity, 12:12 hours of 
light:darkness). In order to quantify their intrinsic variation in feeding rate due to variation in size, 
bumble bees were maintained on a control diet of syrup for three days before dosing began. Once 
dosing began, each cage was provided with a syrup feeder containing either control syrup or a syrup 
with one of the following nine doses of imidacloprid in units of μg imidacloprid L-1: 125.00; 50.00; 
20.00; 8.00; 3.20; 1.28; 0.51; 0.20; 0.08.  Imidacloprid was obtained as a solution in acetonitrile (Dr. 
Ehrenstorfer GmbH, Augsburg, Germany) and the acetonitrile was removed by evaporation with a 
vacuum dryer (ScanVac MaxiVac Beta, Labogene, Lynge, Denmark) and the imidacloprid was 
suspended in water before being mixed into feeder syrup.  
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2.2 Case study 2: lethal vs. sublethal biomarkers in honey bees exposed to imidacloprid 
Both dose-response relationships were obtained from a meta-analysis of experiments testing the 
effects of dietary imidacloprid on honey bees9. The dose-response relationship for sublethal effects 
uses relative performance as the biomarker and it is as described in the first case study.  The dose-
response relationship for lethal effects9 is given by: mortality(%) = 10.2 + [(75.3 – 10.2)/(1 + exp(0.567 
(0.194 – ln(dose))))].  
2.3 Case study 3: feeding vs. fecundity in worker bumble bees exposed to imidacloprid 
Queenless microcolonies14 of four or five worker bumble bees were established from queenright 
colonies of B. terrestris, (Natupol Beehive; Koppert B.V., Berkel en Rodenrijs, Netherlands) in softwood 
boxes (internal dimensions: 120 × 120 × 45 mm).  Each microcolony fed on syrups prepared as 
described above (section 2.1) and at the same range of doses. Each microcolony contained a pollen 
ball that was prepared by grinding pollen pellets collected from honey bee hives (Werner Seip 
Bioprodukte, Butzbach, Germany) into a powder and mixing the mass with water to form dough. 
Brood production was quantified after 14 days of exposure to dosed syrups.  
3. Results 
The daily feeding rates of bumble bees and the sublethal performance of honey bees averaged across 
various biomarkers are equally sensitive to dietary imidacloprid up to 125 g L-1 (Figure 1). In honey 
bees, sublethal performance biomarkers are more sensitive than mortality to dietary imidacloprid up 
to 125 g L-1 (Fig 2). Performance is predicted to decrease by over 50% at a dosage of dietary 
imidaclopid equivalent to 0.1 LD50 (Fig 2). In bumble bees, the fecundity of adult workers in queenless 
microcolonies is more sensitive than the daily feeding rate of individuals to dietary imidacloprid up to 
125 g L-1 (Fig 3). 
 
 
Fig. 1 Response-response relationship showing percentage reduction in the performance of honey bees 
(Apis mellifera) averaged across various sublethal biomarkers (y-axis) versus the percentage 
reduction in daily feeding rate of individual bumble bees (Bombus terrestris; x-axis) when exposed in 
laboratory trials to dietary imidacloprid in feeder syrups at nine doses in units of μg imidacloprid L-1: 
125.00; 50.00; 20.00; 8.00; 3.20; 1.28; 0.51; 0.20; 0.08.  Points are interpolated for ease of inspection 
only. 
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Fig. 2 Response-response relationship showing percentage reduction in the performance of honey bees 
(Apis mellifera) averaged across various sublethal biomarkers (y-axis) versus the percentage increase 
in mortality rate of honey bees averaged across various studies (x-axis) when individuals are 
exposed in laboratory trials to dietary imidacloprid in feed syrup. The abrupt inflection in the 
response-response relation occurs at a dosage of 350 μg imidacloprid L-1. The open circular symbol 
indicates the point on the relationship that corresponds to x = LD50/10, or 5% mortality. 
 
 
 
 
 
Fig. 3 Response-response relationship showing percentage reduction in the fecundity of worker bumble 
bees (Bombus terrestris) in microcolonies (y-axis) versus the percentage reduction in daily feeding 
rate of individual bumble bees (x-axis) when exposed in laboratory trials to dietary  imidacloprid in 
feeder syrups at nine doses in units of μg imidacloprid L-1: 125.00; 50.00; 20.00; 8.00; 3.20; 1.28; 0.51; 
0.20; 0.08. Points are interpolated for ease of inspection only. 
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4. Discussion and conclusions 
The proposition that we can find cross-species generality in toxicological sensitivity in bees receives 
some support from the similarity in dose-dependent responses to dietary imidacloprid between the 
feeding rate of bumble bees and sublethal performance biomarkers in honey bees. Arguably, this 
similarity emerges because the overall health of an individual is equally affected by dietary 
imidacloprid in both species. An individual’s feeding rate probably reflects its levels of metabolic and 
locomotory activity. In honey bees, the sublethal performance biomarkers, such as colony activity and 
individual learning performance, are similarly indicative of overall health. This apparent similarity in 
sensitivity between honey bees and bumble bees contrasts with the substantive disparity between 
their LD50s for imidacloprid. However, we show below that biomarkers can differ substantively in 
sensitivity even within species, and this is so particularly when comparing sublethal markers and 
mortality. We therefore argue that the similarity between honey bees and bumble bees in sensitivity 
in biomarkers of overall health begins to suggest the existence of a generality, but this conclusion is 
highly provisional and it must be properly established by more comparisons across species and 
genera.  
In honey bees, the greater sensitivity of sublethal biomarkers than mortality potentially has 
implications for the security of the conventional testing protocols used by regulators in pesticide 
approval, which typically focus on mortality. In Europe, regulators may give attention to the toxicity-
exposure ratio, TER15, which is calculated as: TER = LD50 / exposure. A compound is declared 
sufficiently non-toxic to bees if its TER  10, which means that, in theory, a compound could be 
approved if the exposure of bees is one tenth of the LD50. Our findings (Fig 2) suggest that it is 
theoretically possible that substantive sublethal effects could emerge at an exposure of 0.1 LD50. 
However, we note that we have demonstrated this only for an insecticidal compound, imidacloprid, 
whose toxicity necessarily yields TER <10. It will be valuable to investigate whether any compound 
that just satisfies the initial screening criterion, i.e. TER = 10, has biologically significant sublethal 
effects at the upper threshold exposure of 0.1 LD50. 
For bumble bees, fecundity was the most sensitive biomarker among those investigated here, 
whereas mortality was the least, if we judge by the relative magnitude of the oral LD50 for 
imidacloprid16, which is about twenty five times greater in bumble bees than in honey bees 
(approximately 200 g kg-1 vs. 8 g kg-1). The high degree of sensitivity of bumble bee fecundity to 
dietary imidacloprid occurs despite the relative insensitivity of mortality as a dose-dependent 
biomarker, which suggests that the magnitude of the LD50 can mislead about the potential of a 
compound to have an ecological impact through demographic toxicity. A pollutant’s demographic 
toxicity describes its impact on a target organism’s population dynamics17, which is determined by 
effects on both birth rates and death rates. If fecundity is more sensitive than mortality, the LD50 
underestimates demographic toxicity. 
The biological basis of the differential sensitivity of fecundity and mortality in bumble bees is largely 
obscure. Imidacloprid, the compound considered here, is neurotoxic to bees. It is understood that the 
bee is a highly integrated physiological unit with many processes under nervous control18, but the 
pronounced sensitivity of fecundity relative to feeding rate, for example, is nevertheless not readily 
explained. We hope that future research into the mechanistic basis of these toxicological effects will 
pay dividends both by increasing our fundamental understanding and also by improving the 
prospects for the development of pesticides with low impacts on bees. 
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